Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
116 USD | -0.96% |
|
-5.31% | +16.59% |
07-02 | Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling | MT |
07-02 | Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B | |
-14.80% | 10.38B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine